As mentioned above, the first Juvéderm filler, Juvéderm XC, was approved by the FDA in 2006. To gain that approval, research had to prove the safety and effectiveness of the filler. Since 2006, Juvéderm and the other fillers in the line have been injected millions of times and have proven to be safe.
Reactions to any Juvéderm filler are exceedingly rare because the primary ingredient is hyaluronic acid, and hyaluronic acid occurs naturally in the human body.
Additionally, in the event that a patient is dissatisfied with the appearance of the injected area, we have the option to administer hyaluronidase, an enzyme that promptly dissolves the hyaluronic acid, restoring the skin to its previous state. Any potential redness or minor swelling at the injection sites typically dissipates rapidly, with immediate and noticeable results.